Awards - Grants & Scholarships - Branislav Radovancevic Memorial Fellowship

ISHLT GRANTS AND AWARDS PROGRAM
GRANTS AND SCHOLARSHIPS
BRANISLAV RADOVANCEVIC MEMORIAL FELLOWSHIP GRANT AWARD
brano radovancevic

The Branislav Radovancevic Memorial Fellowship Grant Award is issued annually in the amount of $75,000.  The funding period is for one year.


APPLICATION:

Applications are no longer being accepted for the January 15, 2014 deadline. If you have any questions about the application process, please contact Phyllis Glenn at 972-490-9495 or phyllis.glenn@ishlt.org.


PURPOSE:

The purpose of the Branislav Radovancevic Memorial Fellowship Grant award is to encourage scholarly clinical work in mechanical circulatory support worldwide, to facilitate scientific exchange regarding MCS, and to provide advanced scholarly clinical training in mechanical circulatory support and total artificial heart therapy.  Dr. Radovancevic, a long-time member of ISHLT, was devoted to the encouragement of scientific collaboration among physicians and scientists engaged in mechanical circulatory support.  This award is intended to encourage others to continue his efforts.

Funding for this award is provided by Thoratec in memory of ISHLT member Branislav (Brano) Radovancevic.


ELIGIBILITY REQUIREMENTS:
  1. The applicant or the applicant's chief of staff / fellowship director must be a member of the ISHLT in good standing at the time of application, and the grant recipient must become a member of ISHLT prior to funding and remain so throughout the period of funding.
  2. The applicant must have completed a residency or the equivalent in one of the following:
    a) general surgery and be eligible for residency/fellowship or the equivalent in cardiothoracic surgery
    b) internal medicine and fellowship in general cardiology and must be eligible for training in advanced heart failure.
  3. The applicant must have met all of requirements for licensure in the state and/or country in which the Fellowship will take place. It is the institution’s responsibility to assure that such requirements have been met.
Funding Stipulations/Award Policies
  1. The Fellowship must begin between April 1 and December 31 of the award year.
  2. The period of training for which the funds will be used may not be less than 12 months.
  3. The funds must be used for advanced scholarly clinical training in mechanical circulatory support and total artificial heart therapy and cannot be used to supplement other funding received for the same work.
  4. At least 25% of the fellow’s time must be devoted to research, with the balance devoted to clinical practice.
  5. At completion it is expected that surgically trained fellows will demonstrate proficiency by satisfying Joint Commission requirements for implantation experience with at least 10 long term Ventricular Assist Devices (“VADs”). Fellows from a physician trained background will demonstrate proficiency by obtaining experience of the pre-operative, peri-operative and long term managements of 10 patients undergoing implantation of VADs.
  6. The fellow is expected to learn postoperative care and management of complications after VAD implant.
  7. The fellow is expected to participate in educational and training programs for mechanical circulatory support.
  8. The fellowship should include appropriate proficiency testing or evaluative processes administered by the teaching physician, in addition to Joint Commission requirements.
  9. Candidates must demonstrate a strong desire to continue to build and support the Mechanical Circulatory Support field when they go into practice.
  10. The results of funded research must be submitted in one of the following formats within two years of the initial date of funding:

    •  as a manuscript to the Journal of Heart and Lung Transplantation
    •  as an abstract for the ISHLT Annual Meeting and Scientific Sessions
  11. The results of funded research cannot have been previously published or presented prior to publication in the Journal of Heart and Lung Transplantation or presentation at the ISHLT Annual Meeting.
  12. ISHLT must be acknowledged as a funding source in all manuscripts and presentations derived from the funded research via the following statement, "This work was supported by a research award from the International Society for Heart and Lung Transplantation." Copies of these publications must be submitted to the ISHLT Headquarters office.
  13. Funding will be awarded in two portions. 50% of the funding will be provided initially, with the remaining 50% provided upon submission of a satisfactory progress report to the Awards Committee 6 months after the date of initial funding. The second installment of funding will not be made if the fellowship is no longer being conducted at the original institution.
  14. The award recipient and the award recipient's institution agree that the funds will be expended for the purpose(s) described in the application, that there is no duplicate funding for these purposes, and that no portion of the award will be used to pay for indirect costs or institutional overhead.
  15. The award recipient or his/her fellowship program director must be present at the Awards Session during the ISHLT Annual Meeting to receive acknowledgment of the award.
Text SizeIncrease Font SizeDecrease Font Size